Every person on your child’s team has the same goal: to give your child the best possible care. We provide medical care, emotional support and much more. Each team member has extensive experience in the treatment of children using immunotherapy.
Jan 27, 2020
The $200,000 award will fund research to develop a novel therapeutic that ignites the immune system and could act as a stand-alone treatment, as well as boost the effectiveness of existing immunotherapies.
Jan 28, 2020
Latest news including elections to NAM, cures for picky eaters, lawn mower injuries and more.
Jan 23, 2020
CHOP has opened a phase 1 trial using CAR T for tough acute myeloid leukemia, hoping to replicate the therapy’s success for acute lymphoblastic leukemia.
Nov 7, 2019
Families make long journeys — and even relocate — so their children can receive specialized treatment at CHOP.
Oct 21, 2019
The National Academy of Medicine elects two global leaders in cellular and gene therapy from Children’s Hospital of Philadelphia.
Oct 21, 2019
Stephan Grupp, MD, PhD, Chief of the Cell Therapy and Transplant Section in the Division of Oncology, has been elected into the National Academy of Medicine (NAM).
Jan 11, 2019
An alternative, humanized CD19 CAR T product for first relapse of pediatric ALL is being evaluated in a clinical trial at Children's Hospital of Philadelphia.
Nov 27, 2018
CHOP researchers analyze how some cancer cells resist a groundbreaking cellular therapy, and have found clues to overcoming that resistance.
Nov 1, 2018
The grand opening of CHOP’s new Clinical Manufacturing Facility highlights its role in manufacturing tools for 21st century precision medicine, to bring innovative treatments to patients.
Jan 24, 2019
Trials of more game-changing cell therapies for pediatric cancer and other diseases are underway or on the horizon at Children's Hospital of Philadelphia.